Showing 1,901 - 1,920 results of 69,060 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.33s Refine Results
  1. 1901
  2. 1902
  3. 1903
  4. 1904
  5. 1905
  6. 1906
  7. 1907
  8. 1908

    Image_5_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  9. 1909

    Excel data file with all collected data. by Marcus Persson (20496333)

    Published 2025
    “…SD = 11.6) after the last day of treatment. 25% (n = 5) met the response criteria, with a mean time to response of 2.2 days (min = 1, max = 3. …”
  10. 1910
  11. 1911
  12. 1912
  13. 1913
  14. 1914
  15. 1915
  16. 1916
  17. 1917

    Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

    Published 2013
    “…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”
  18. 1918
  19. 1919
  20. 1920

    Decreased mTOR expression. by Sandra Müller-Krebs (485766)

    Published 2013
    “…<p>Western blot analysis of podocytes showing decreased expression of total mTOR protein with increasing concentrations (0–100 nM) of EVL and SRL after 48 h of incubation, respectively (A, B); no differences in mTOR expression analyzing EVL and SRL (20 nM) simultaneously (C); α-tubulin served as loading control. mTOR = mammalian target of rapamycin; EVL = Everolimus; SRL = Sirolimus; C<sub>Ø</sub> = untreated control; C = solvent ethanol control; PAN = puromycin aminonucleoside.…”